Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological cancers. Despite improvements in medical treatments, the prognosis for EOC remains poor, and there is an urgent need for new therapeutic strategies. Immune checkpoint inhibitors (CPIs) have dramatically improved surviv...

Full description

Bibliographic Details
Main Authors: Fulvio Borella, Eleonora Ghisoni, Gaia Giannone, Stefano Cosma, Chiara Benedetto, Giorgio Valabrega, Dionyssios Katsaros
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Diagnostics
Subjects:
ovarian cancer
immunotherapy
immune checkpoint inhibitors
safety
biomarkers
clinical trials
Online Access:https://www.mdpi.com/2075-4418/10/3/146

Internet

https://www.mdpi.com/2075-4418/10/3/146

Similar Items